|

OMT strategy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Beijing Anzhen Hospital1

Indications

  • Thin-cap fIbroatheroma1
  • Vulnerable Coronary Plaques1
  • Acute Coronary Syndromes (ACS)1
  • Coronary Arterial Disease (CAD)1
  • Heart Disease1

Other1 trial

Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.